生物引导放疗:重新定义放疗在转移性癌症中的作用
转移性癌症的生物学认识及概念验证临床试验提示,减灭全部大体肿瘤有望改善患者结局,但常规外照射放疗系统消融多个靶点负担重。生物引导放疗(BgRT)将PET-CT与6 MV直线加速器结合,直线加速器以亚秒级延迟对肿瘤PET发射连续响应,使沉积剂量实时追踪肿瘤。该技术有望以高效且可推广的方式实现完全转移灶消融。
要点
- BgRT将PET-CT与6 MV直线加速器结合,利用肿瘤PET发射信号实时引导放疗。
- 直线加速器以亚秒级延迟对肿瘤PET发射连续响应,使沉积剂量实时追踪肿瘤。
- 静脉注射放射性示踪剂后肿瘤成为自身基准点,有望实现完全转移灶消融。
核心结论
- 概念验证临床试验提示减灭全部大体肿瘤有望改善患者结局,BgRT有潜力以对单个患者高效且可推广至整个转移性疾病人群的方式实现完全转移灶消融。
研究设计与样本
- 原文为综述性文章,未报告系统检索范围、纳入文献数量或样本量。
临床应用与阅片要点
- BgRT通过静脉注射放射性示踪剂使肿瘤成为自身基准点,利用PET发射信号以亚秒级延迟引导直线加速器束流实时追踪肿瘤。
- 未来趋势可能进一步增强BgRT在临床中的效用,该技术与新型剂量绘画和分割方案、放射组学及新放射性示踪剂等放疗创新相衔接。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The emerging biological understanding of metastatic cancer and proof-of-concept clinical trials suggest that debulking all gross disease holds great promise for improving patient outcomes. However, ablation of multiple targets with conventional external beam radiotherapy systems is burdensome, which limits investigation and utilization of complete metastatic ablation in the majority of patients with advanced disease. To overcome this logistical hurdle, technical innovation is necessary. Biology-guided radiotherapy (BgRT) is a new external beam radiotherapy delivery modality combining positron emission tomography-computed tomography (PET-CT) with a 6 MV linear accelerator. The key innovation is continuous response of the linear accelerator to outgoing tumor PET emissions with beamlets of radiotherapy at subsecond latency. This allows the deposited dose to track tumors in real time. Multiple new hardware and algorithmic advances further facilitate this low-latency feedback process. By transforming tumors into their own fiducials after intravenous injection of a radiotracer, BgRT has the potential to enable complete metastatic ablation in a manner efficient for a single patient and scalable to entire populations with metastatic disease. Future trends may further enhance the utility of BgRT in the clinic as this technology dovetails with other innovations in radiotherapy, including novel dose painting and fractionation schemes, radiomics, and new radiotracers.
引用
- Shirvani SM, Huntzinger CJ, Melcher T, et al. Biology-guided radiotherapy: redefining the role of radiotherapy in metastatic cancer. Br J Radiol. 2020. PMID: 33112685. doi:10.1259/bjr.20200873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。